Odyssey Therapeutics
San Francisco
About Odyssey Therapeutics
Odyssey Therapeutics is a computational immunology company that develops novel therapeutics for patients with autoimmune diseases. Using modern machine learning techniques, Odyssey is transforming the landscape of autoimmune treatments. Odyssey Therapeutics was founded in 2018 and is based in San Francisco, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $101.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2021)
- Website: odysseytherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Machine Learning, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/odyssey-therapeutics-83100 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.